Molecular Resilience, Inc and other shareholders entered into a letter of intent to sell Fortitude Group, Inc. (OTCPK:FRTD) for $3 million in stock on May 18, 2014. The buyer will exchange each share of Fortitude with its share at consideration of $0.12 per share. The letter of intent includes a 10 day due diligence period with an estimated closing date for the transaction of May 30, 2014.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | 0.00% |
2021 | Analysis: Chasing yield, U.S. private equity firms nudge up risk on insurers | RE |
2021 | Chasing yield, U.S. private equity firms nudge up risk on insurers | RE |
1st Jan change | Capi. | |
---|---|---|
0.00% | 737 | |
-0.02% | 121B | |
+5.06% | 98.23B | |
+14.71% | 67.63B | |
+23.75% | 65.62B | |
+13.66% | 43.97B | |
+15.68% | 43.64B | |
+22.97% | 36.24B | |
+7.43% | 25.7B | |
+0.58% | 23.37B |
- Stock Market
- Equities
- FRTD Stock
- News Fortitude Group, Inc.
- Molecular Resilience, Inc and other shareholders entered into a letter of intent to sell Fortitude Group, Inc. for $3 million.